Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis
Clinical trial NCT06764862 · COMPLETED
Trial details
- NCT number
- NCT06764862
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-17
- Primary completion
- 2026-02-12
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.